| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/03/2010 | CN100586425C Cinnamon poria capsule and its preparation process |
| 02/03/2010 | CN100586424C Chinese medicinal formulation, preparation process and quality control method |
| 02/03/2010 | CN100586423C Popping oral pharmaceutical compositions |
| 02/03/2010 | CN100586422C Bivalirudin freeze-dried injection and preparation thereof |
| 02/03/2010 | CN100586421C Ligustrazine microcosmic salt liposome medicine and preparing method |
| 02/03/2010 | CN100586420C Astragaloside injection and preparation method thereof |
| 02/02/2010 | US7655768 Galactose derivative, drug carrier and medicinal composition |
| 02/02/2010 | US7655717 Ointment composition for treating decubitus ulcers and methods for its making and its use |
| 02/02/2010 | US7655692 Dissolving atorvastatin in alcoholic solvent comprising methanol, ethanol, 1-propanol, or isopropanol; high speed evaporation by spray drying |
| 02/02/2010 | US7655681 Administering zonisamide; clearing mucus; protective patches |
| 02/02/2010 | US7655468 Noncovalent complex having net positive charge at pH 6.0-8.0, the complex comprising a nucleic acid, at least one cationic lipid, and a polycation, where polycation is a cationic peptide or a polypeptide comprising polylysine, polyornithine, or polyarginine; gene therapy |
| 02/02/2010 | US7655435 For eukaryotic in vitro expression; silicone-based surfactants and microcapsules; phage display |
| 02/02/2010 | US7655261 Medicament and method of treatment of patients with heavy metals |
| 02/02/2010 | US7655259 Delayed release carnitine |
| 02/02/2010 | US7655258 Biodegradable copolymer, and polymeric micelle composition containing the same |
| 02/02/2010 | US7655257 Impermeable reservoir divided into water-swellable agent/drug chambers; fluid from environment imbibed through semipermeable plug into the water-swellable agent chamber releasing drug through a back-diffusion regulating outlet; delivering leuprolide acetate for advanced prostate cancer for 2 years |
| 02/02/2010 | US7655256 Pharmaceutical formulation including a resinate and an aversive agent |
| 02/02/2010 | US7655255 Topical composition for transdermal administration |
| 02/02/2010 | US7655252 Antimicrobial nanoemulsion compositions and methods |
| 02/02/2010 | US7655236 Lanthionine antibiotic compositions and methods |
| 02/02/2010 | US7655226 Treatment of Pompe's disease |
| 02/02/2010 | US7655218 Methods and compositions for detection and diagnosis of infectious diseases |
| 02/02/2010 | US7655174 Combination of high viscosity and slower acting low viscosity resins, curable toughener, initiator and stabilizer; rapid homogeneous droplet merging and curing; tensile strength, ductility; computer controlled piezoelectric printing of three dimensional multilayer articles |
| 02/02/2010 | US7655001 Temperature responsive systems |
| 02/02/2010 | US7654997 Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat |
| 02/02/2010 | CA2477756C Modified phosphocalcic compound, injectable composition containing same |
| 02/02/2010 | CA2468563C Calcium metasilicates and methods for making the same |
| 02/02/2010 | CA2462529C Bioactive surface modifiers for polymers and articles made therefrom |
| 02/02/2010 | CA2460306C Stable and taste masked pharmaceutical dosage form using porous apatite grains |
| 02/02/2010 | CA2440539C Method and device for producing small, thin sheets from an active-ingredient film |
| 02/02/2010 | CA2436752C Bifidobacteria and preparations containing them |
| 02/02/2010 | CA2430791C Ionophore antibiotic formulations |
| 02/02/2010 | CA2424186C Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof |
| 02/02/2010 | CA2407994C Reductive alkylation process |
| 02/02/2010 | CA2383412C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 02/02/2010 | CA2321819C Xylitol compositions for treating upper respiratory conditions |
| 02/02/2010 | CA2160898C Alimentative infusion liquids for administration through peripheral vein |
| 01/31/2010 | CA2674006A1 Microemulsions |
| 01/28/2010 | WO2010011927A1 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 01/28/2010 | WO2010011833A1 Secure tracking of tablets |
| 01/28/2010 | WO2010011622A2 Ophthalmic gallium compositions and methods of their use |
| 01/28/2010 | WO2010011609A2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011605A2 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011597A2 Treatment of obesity and related disorders |
| 01/28/2010 | WO2010011541A2 Topical anti-inflammatory combination |
| 01/28/2010 | WO2010011522A1 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| 01/28/2010 | WO2010011466A2 Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011343A2 Methods for treating viral disorders |
| 01/28/2010 | WO2010011319A2 Magnetic heating for drug delivery and other applications |
| 01/28/2010 | WO2010011289A2 Parenteral and oral formulations of benzimidazoles |
| 01/28/2010 | WO2010011232A1 Stabilized atypical antipsychotic formulation |
| 01/28/2010 | WO2010010985A1 Multi-layered lamellar granule and skin external application composition containing same |
| 01/28/2010 | WO2010010939A1 Prophylactic or therapeutic agent for age-related macular degeneration |
| 01/28/2010 | WO2010010902A1 Microcapsule, process for production thereof, and food or beverage containing microcapsule |
| 01/28/2010 | WO2010010756A1 Water-soluble acrylic acid salt polymer and gelling base |
| 01/28/2010 | WO2010010715A1 Stable aqueous solution composition containing sulfonamide compound |
| 01/28/2010 | WO2010010689A1 Liquid preparation for contact lenses |
| 01/28/2010 | WO2010010579A1 Multiple unit dosage form of niacin |
| 01/28/2010 | WO2010010568A1 Oral compositions of clindamycin |
| 01/28/2010 | WO2010010470A2 Methods of administering topical antifungal formulations for the treatment of fungal infections |
| 01/28/2010 | WO2010010431A1 Self-nano-emulsifying curcuminoids composition with enhanced bioavailability |
| 01/28/2010 | WO2010010367A1 Solid pharmaceutical composition comprising exemestane |
| 01/28/2010 | WO2010010257A2 Appetising medicaments for oral administration in solid form for prevention and/or treatment of cardiac insufficiency in animals |
| 01/28/2010 | WO2010010256A2 Appetising medicament for oral administration in solid form |
| 01/28/2010 | WO2010010240A2 Dermal patch for applying dry active agents |
| 01/28/2010 | WO2010010223A1 Use of microparticles containing genetically modified cells in the treatment of neurodegenerative diseases |
| 01/28/2010 | WO2010009961A1 Pharmaceutical formulation for treating the upper digestive tract |
| 01/28/2010 | WO2010009900A1 Paliperidone composition comprising solid matrix particles |
| 01/28/2010 | WO2010009891A1 Pharmaceutical dosage forms for time-specific drug delivery |
| 01/28/2010 | WO2010009808A1 Preparation and iontophorectic device for the transdermal application of active ingredients |
| 01/28/2010 | WO2010009745A1 Solid oral dosage form containing anti-platelet agent clopidogrel and method for the preparation thereof |
| 01/28/2010 | WO2010009619A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 01/28/2010 | WO2010009618A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 01/28/2010 | WO2010009573A1 A pharmaceutical composition for regulating the potassium channel in cardiac muscle cell and its preparation method and its uses |
| 01/28/2010 | WO2010009492A1 ATOVAQUONE WITH A PARTICLE SIZE DIAMETER RANGE (D90) OF GREATER THAN 3 μM TO ABOUT 10 μM |
| 01/28/2010 | WO2009133325A3 Polymerized micelles |
| 01/28/2010 | WO2009129439A3 Medical devices and methods including polymers having biologically active agents therein |
| 01/28/2010 | WO2009129432A3 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
| 01/28/2010 | WO2009129149A4 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
| 01/28/2010 | WO2009129148A3 Methods and compositions for treating intervertebral disc herniations |
| 01/28/2010 | WO2009125987A9 Pharmaceutical formulation |
| 01/28/2010 | WO2009125944A9 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker |
| 01/28/2010 | WO2009120978A3 Treatment of metabolic-related disorders using hypothalamic gene transfer of bdnf and compositions therfor |
| 01/28/2010 | WO2009120844A3 Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue |
| 01/28/2010 | WO2009120365A3 Methods and compositions for the delivery of agents |
| 01/28/2010 | WO2009117130A3 Extended release forumulation containing a wax |
| 01/28/2010 | WO2009078034A3 Orally disintegrating tablets of ropinirole hydrochloride |
| 01/28/2010 | WO2009075859A3 Formulation of insulinotropic peptide conjugates |
| 01/28/2010 | WO2009073661A3 Compositions comprising coenzyme q-io and garlic oil for an increased coenzyme q-10 bioavailability |
| 01/28/2010 | WO2009051845A3 Biodegradable implants with controlled bulk density |
| 01/28/2010 | WO2009047826A8 Pharmaceutical composition comprising sucralphate and mesalazine |
| 01/28/2010 | WO2008157057A3 Locally administrated low doses of corticosteroids |
| 01/28/2010 | WO2008125843A9 Pharmaceutical compositions |
| 01/28/2010 | WO2005102281A3 Porous calcium phosphate networks for synthetic bone material |
| 01/28/2010 | US20100024071 Methods for treating or preventing infestation |
| 01/28/2010 | US20100022992 Drug Delivery Device |
| 01/28/2010 | US20100022945 Implantable drug delivery system |
| 01/28/2010 | US20100022659 Methods and Compositions for the Treatment of CNS-Related Conditions |
| 01/28/2010 | US20100022657 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 01/28/2010 | US20100022577 Dry syrup containing loratadine |